A Dominant Loss-of-Function GJA1 (Cx43) Mutant Impairs Parturition in the Mouse by Tong, Dan et al.
Western University
Scholarship@Western
Physiology and Pharmacology Publications Physiology and Pharmacology Department
6-1-2009
A Dominant Loss-of-Function GJA1 (Cx43)
Mutant Impairs Parturition in the Mouse
Dan Tong
University of Western Ontario
Xuerong Lu
University of Western Ontario
Hong-Xing Wang
University of Western Ontario
Isabelle Plante
University of Western Ontario, iplante@uwo.ca
Ed Lui
University of Western Ontario
See next page for additional authors
Follow this and additional works at: https://ir.lib.uwo.ca/physpharmpub
Part of the Medical Physiology Commons, and the Obstetrics and Gynecology Commons
Citation of this paper:
Tong, Dan; Lu, Xuerong; Wang, Hong-Xing; Plante, Isabelle; Lui, Ed; Laird, Dale W.; Bai, Donglin; and Kidder, Gerald M., "A
Dominant Loss-of-Function GJA1 (Cx43) Mutant Impairs Parturition in the Mouse" (2009). Physiology and Pharmacology
Publications. 3.
https://ir.lib.uwo.ca/physpharmpub/3
Authors
Dan Tong, Xuerong Lu, Hong-Xing Wang, Isabelle Plante, Ed Lui, Dale W. Laird, Donglin Bai, and Gerald M.
Kidder
This article is available at Scholarship@Western: https://ir.lib.uwo.ca/physpharmpub/3
  
1
1
A Dominant Loss-of-Function GJA1 (Cx43) Mutant Impairs Parturition in the Mouse 
Dan Tong1-3, Xuerong Lu1, Hong-Xing Wang1-3, Isabelle Plante5, Ed Lui1, Dale W. Laird1,5, 
Donglin Bai1, and Gerald M. Kidder1-4,* 
 
1Departments of Physiology and Pharmacology, 2Obstetrics and Gynaecology, 3Paediatrics, and 
5Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, The University of 
Western Ontario, London, ON and 4Children’s Health Research Institute, 800 Commissioners 
Road East, London, ON 
 
*Address for correspondence: Dr. Gerald M. Kidder, Department of Physiology and 
Pharmacology, Schulich School of Medicine and Dentistry, The University of Western Ontario 
London, ON  N6A 5C1. tel: 519-661-3132; fax: 519-850-2562; gerald.kidder@schulich.uwo.ca 
 
This work was funded by a grant (reference number MOP-74637) from the Canadian Institutes 
of Health Research (CIHR) to D.B., G.M.K., and D.W.L.  D.T. was supported by a CIHR Canada 
Graduate Scholarship Doctoral Award. 
 
Short title: Effects of a GJA1 mutant on parturition 
Summary sentence: The G60S mutant of the gap junction protein GJA1 (Cx43) has a dominant-
negative effect on wild-type Cx43 function in the mouse myometrium, severely reducing gap 
junctional coupling leading to impaired parturition. 
Key words: connexin43, gap junction, myometrium, intercellular communication, 
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ABSTRACT 
Expression of GJA1 (commonly known as connexin43 or Cx43), a major myometrial gap 
junction protein, is upregulated before the onset of delivery, suggesting an essential role of Cx43 
mediated gap junctional intercellular communication (GJIC) for normal uterine contraction 
during parturition. To determine how a disease-linked Cx43 mutation affects myometrial 
function, we studied a mutant mouse model carrying an autosomal dominant mutation (Gja1Jrt) 
in the gene encoding Cx43 that displays features of the human genetic disease, oculodentodigital 
dysplasia (ODDD).  We found that Cx43 level, specifically the phosphorylated species of the 
protein, is significantly reduced in the myometrium of the mutant mice (Gja1Jrt/+) as revealed by 
western blotting and immunostaining. Patch-clamp electrophysiological measurements 
demonstrated that coupling between myometrial smooth muscle cells (SMCs) is reduced to 
<15% of wildtype, indicating that the mutant protein acts dominantly on its wildtype counterpart. 
The phosphorylated species of Cx43 in the mutant myometrium failed to increase prior to 
parturition as well as in response to exogenous estrogen. Correspondingly, in vitro experiments 
with uterine strips revealed weaker contraction of the mutant myometrium and reduced 
responsiveness to oxytocin, providing an explanation for the prolonged gestation and presence of 
suffocated fetuses in the uteri that was observed in some of the mutant mice. We conclude that 
the Gja1Jrt mutation has a dominant-negative effect on Cx43 function in the myometrium, 
severely reducing GJIC leading to impaired parturition.  
 
 
 BOR Papers in Press. Published on January 28, 2009 as DOI:10.1095/biolreprod.108.071969
 Copyright 2009 by The Society for the Study of Reproduction.
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INTRODUCTION 
Gap junctions are specialized plasma membrane domains containing arrays of channels that 
exchange ions and small molecules between neighboring cells, enabling cells to directly 
cooperate with each other both electrically and metabolically [1]. An intercellular gap junction 
channel consists of two hemichannels (connexons) docked end-to-end, each of which is 
composed of six connexin proteins. To date, 20 and 21 connexin genes have been identified in 
the mouse and human genomes, respectively, which have distinct, but overlapping patterns of 
expression [1].   
 
In humans and other mammals, the sudden appearance of numerous gap junctions within the 
myometrium is one of the many steps that occur during the conversion of the uterus from the 
quiescent state of pregnancy to the active state of labor [2]. Four different connexins, Cx26 
(GJB2), Cx40 (GJA5), Cx43, and Cx45 (GJC1) have been identified in the myometrium, but 
they are differentially regulated during pregnancy. Expression of Cx26 is highest during late 
pregnancy but decreases before the onset of labor [3]. Cx45 is present in the nonpregnant uterus 
and during early pregnancy but declines thereafter [4]. Cx40 was found in human myometrial 
cells [5], but there is no evidence that its expression is regulated during pregnancy. In contrast, 
Cx43 gap junctions are scarce in the myometrium of the nonpregnant uterus, but increase 
significantly just before the onset of labor and then disappear shortly after delivery [3, 6], 
indicating that Cx43 expression is temporally associated with parturition. Functional studies have 
shown that the ability to propagate action potentials along the myometrium is enhanced during 
parturition [7, 8]. Direct measurements by dual voltage clamp and dye microinjection also 
confirmed that gap junctional intercellular communication (GJIC) between myometrial myocytes 
is significantly elevated during parturition, consistent with the increased Cx43 protein level [9]. 
It is believed that this extensive connectivity within the myometrium is essential for the 
synchronized contractions required to expel the fetus and placenta.   
 
Well-defined hormonal regulation of Cx43 expression has been observed in the myometrium. 
Cx43 expression is suppressed by progesterone and elevated by estrogen [10-12]. It is believed 
that the downregulation of Cx43 by progesterone maintains the myometrium in a quiescent state 
during pregnancy, avoiding muscle contraction that could lead to premature labor.  Prior to the 
onset of labor, Cx43 mRNA and protein levels in the myometrial myocytes increase in 
association with an increase of plasma estrogen/progesterone ratio. In addition to hormonal 
signals, Cx43 expression is also upregulated by uterine stretch as a result of the increasing 
intrauterine volume caused by pregnancy [6]. The importance of Cx43-mediated GJIC for 
parturition was demonstrated by myometrial specific ablation of the Gja1 gene in the mouse 
using Cre-LoxP system. The myometrial Cx43 level was reduced by ~70%, which resulted in a 
prolongation of pregnancy and intrauterine death of some pups [13].  
 
Oculodentodigital dysplasia (ODDD) is a rare human autosomal dominant disorder caused by 
mutations in the GJA1 gene encoding Cx43. Common symptoms include syndactyly of hands 
and feet, enamel hypoplasia, craniofacial abnormalities, ophthalmic defects and occasionally 
heart and neurological dysfunction [14, 15].  More than 39 different mutations in GJA1 have 
been identified so far [1]. In vitro studies of the ODDD-linked Cx43 mutants have shown that 
most will assemble into gap junction plaque-like structures at the cell surface, however, all 
mutants investigated to date exhibit severely reduced GJIC as compared to wildtype Cx43. 
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Furthermore, when co-expressed, the mutants typically act to inhibit the function of wildtype 
Cx43 [16-18].    
 
In 2005, a line of mutant mice (Gja1Jrt/+) with several of the classic symptoms of ODDD 
including syndactyly, enamel hypoplasia, and craniofacial anomalies was generated by N-ethyl-
N-nitrosourea mutagenesis [19].  These mice carry a G60S amino acid substitution in the first 
extracellular loop of Cx43, one residue removed from the P59H mutation identified in some 
human ODDD patients [20]. Consistent with in vitro studies, Cx43G60S also severely impaired 
Cx43-mediated GJIC in various tissues of the mutant mice [19, 21].  In the present study, we 
sought to determine the effect of this disease-linked Cx43 mutation on myometrium function. 
Given the important role of Cx43 in synchronizing myometrial contraction, we hypothesized that 
the Cx43G60S mutant affects parturition by inhibiting gap junctional coupling between the 
myometrial smooth muscle cells.  
 
MATERIALS AND METHODS 
Mouse Breeding and Genotyping  
All animal experiments were approved by the Animal Use Subcommittee of the University 
Council on Animal Care at the University of Western Ontario. The Gja1Jrt/+ mice were generated 
at the Centre for Modeling Human Disease, University of Toronto, and were kindly provided by 
Dr. Janet Rossant.  The original mice were on a mixed C57BL/6J and C3H/HeJ background [19] 
and were backcrossed to C57BL/6J for up to 4 generations. Genotypes were determined by 
polymerase chain reaction (PCR) as previously described [19]. Mice were housed under 
controlled lighting (12 h light, 12 h dark) and temperature (21–24 °C) conditions.  
 
Animal Treatment and Tissue Preparation 
Sexually mature 6- to 8- week-old females were used. In nonpregnant females, the stage of the 
estrus cycle was determined by microscopic examination of vaginal smears [22] and those at 
proestrus stage were selected for experiment. Females were injected intraperitoneally with 5 IU 
equine chorionic gonadotropin (eCG) (Sigma-Aldrich Canada, Oakville, ON cat. no. G4877) or 
subcutaneously with 5 µg 17β-estradiol (Sigma-Aldrich E2758) dissolved in sesame oil. They 
were killed by cervical dislocation following CO2 anesthesia 40 hours after eCG treatment or 12 
hours after estradiol treatment. For pregnancy testing, one female and one wildtype male were 
housed together to mate. The presence of a vaginal plug was taken as evidence of mating and the 
morning of plug detection was termed day 0.5 of gestation. Pregnant females were killed at day 
18.5 of gestation.  
 
For immunostaining, the uterine horns were removed from the body and fixed in Bouin’s 
solution for 12 hours. For western blotting, the uterine horns were placed on ice cold glass slides 
and opened longitudinally. The endometrium was carefully scraped off using a spatula. 
Alternatively, whole uteri were prepared for western blotting.  The tissue was homogenized in 
single-detergent lysis buffer (50 mM Tris-Cl pH = 8.0, 150 mM NaCl, 0.02% sodium azide, 100 
µg/ml PMSF, 1 µg/ml aprotinin, 1% Triton X-100)  supplemented with 1 mM NaF, 1 mM 
Na3VO4 and protease inhibitor cocktail (1 tablet per 10 ml buffer; Sigma-Aldrich). For recording 
contraction, a 1 x 0.5 cm longitudinal strip of uterus was cut from the middle section of the 
uterine horns and immediately mounted in an organ bath.  
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Isometric Recording of Uterine Contraction 
Uterine strips were placed longitudinally in a 12-ml organ bath containing Krebs–Ringer–
Bicarbonate (KRB) solution with the following composition (mM): NaCl, 120; KCl, 4.6; 
KH2PO4, 1.2; MgSO4, 1.2; CaCl2, 1.5; NaHCO3, 20, and glucose 11. KRB solution, pH 7.4, was 
maintained at 37 °C and gassed continuously with a mixture of 95% O2–5% CO2. Each uterine 
strip was placed under a resting force of 1 g and allowed to equilibrate for 1 h before exposure to 
drugs. The contractile responses of the strips were recorded isometrically with a tension 
transducer (MLT 0201/D) connected to a Powerlab bridge (AD Instruments Pty Ltd). Chart for 
Windows 5 software (AD Instruments Pty Ltd) was used to display and analyze the tension 
changes in the tissue.  Oxytocin (Sigma-Aldrich), ranging in final concentration from 0.03 to 30 
mIU/ml, was applied by pipette to the bottom of the chamber in increasing order. There was a 10 
min interval between each application of oxytocin. At the end of each experiment, the 
superfusate was changed from KRB solution to distilled water to induce a large contraction of 
the tissue (hypotonic shock) [23, 24], which was used as a reference contraction (100 %).   
 
Isolation and Culture of Myometrial Smooth Muscle Cells  
Primary cultures of myometrial smooth muscle cells (SMCs) were prepared as described 
previously [25]. Briefly, uteri were placed in Hanks basic salt solution (HBSS) (Invitrogen 
Canada, Burlington, ON) supplemented with 2.25 mmol/L HEPES (Buffer A) and cut into small 
pieces. Then the tissues were washed three times with buffer B (Buffer A without calcium and 
magnesium) and digested at 37°C with agitation (100 rpm) for 30 minutes by the addition of 1 
mg/ml collagenase type II, 0.15 mg/ml deoxyribonuclease I, 0.1 mg/ml soybean trypsin inhibitor, 
1 mg/ml bovine serum albumin (all from Sigma-Aldrich), and 10% fetal bovine serum (FBS) 
(Invitrogen) in buffer B. After incubation, the mix was gently pipetted to aid enzymatic digestion. 
Equal amounts of buffer B supplemented with 10% FBS was added, and the mixture was passed 
through a cell strainer and stored on ice.  Fresh enzyme mix was added to the remaining 
undigested tissue, and the incubation-aspiration process was repeated for 3-4 times. The first 
incubation solution was discarded and the remaining solutions were collected in a 50 ml Falcon 
tube. The dissociated cells were collected by centrifugation (200 x g, 10 min), and the cell pellets 
were resuspended in sterile, phenol red-free Dulbecco’s modified Eagle’s medium (Invitrogen) 
supplemented with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin (Invitrogen).  To 
selectively enrich for uterine SMCs, the cell mixture was pre-plated in a 60 mm culture dish for 
45 minutes at 37°C. The supernatant that contained the slowly adhering SMCs was collected and 
plated on 12 mm glass coverslips coated with type I collagen (BD Biosciences 354236, 
Mississauga, ON). All experiments were carried out on day 2 or 3 of culture.  
 
Immunofluorescent Staining 
Fixed uterine tissues were embedded in paraffin and sectioned continuously at a thickness of 5 
μm. Sections were then deparaffinized and washed 3 times with phosphate-buffered saline (PBS) 
before blocking with 2% bovine serum albumin (BSA, Sigma-Aldrich) in PBS for 1 hour. Cx43 
was detected using a rabbit polyclonal antibody (1:500) (Sigma-Aldrich C6219); in addition to 
western blotting (see Results), the specificity of this antibody was verified by showing the 
absence of immunostaining in mouse tissue lacking Cx43.  The SMCs were labeled with a 
monoclonal mouse antibody against α-actin (1:800, Sigma-Aldrich A2547); this antibody has 
been characterized previously and its specificity demonstrated by western blotting and 
immunostaining of tissues expressing other actin isoforms but lacking α-smooth muscle actin 
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[26].  Appropriate Alexa594 or Alexa488 conjugated anti-mouse and anti-rabbit secondary 
antibodies were used at a 1:200 dilution (Invitrogen A11005, A11012, A11001, A11008). 
Parallel sections were stained with secondary antibody alone (negative control). Nuclei were 
labeled with Hoechst 33342 (1:1000 dilution; Molecular Probes). Slides were imaged on a Zeiss 
(Thornwood, NY) LSM 510 META confocal microscope. For immunostaining on cultured 
SMCs, cells grown on glass coverslips were fixed with ice cold 80% methanol/20% acetone for 
20 minutes before immunolabeling as described above.  
 
Patch Clamp Recording 
Single-electrode whole cell patch-clamp recording was used to measure SMC membrane 
capacitance and gap junctional conductance as described [27]. Briefly, pipettes were made from 
borosilicate glass capillaries using a two-stage pipette puller (PP-83; Narishige, Tokyo, Japan). 
The intracellular pipette solution contained (in mM) 70 KCl, 65 CsCl, 5 NaCl, 2 EGTA, 2.5 
MgCl2, 5 TEA-Cl, and 10 HEPES, pH 7.3, and pipettes had a resistance of 3–5 M .  Cells on 
coverslips were transferred to a 2 ml recording chamber mounted on the stage of an inverted 
microscope (Olympus IMT-2). Cells were bathed in solution containing (in mM) 130 NaCl, 5 
KCl, 1.2 MgCl2, 1.5 CaCl2, 10 Glucose and 10 HEPES, pH 7.4. Voltage clamp for whole-cell 
recordings was carried out with an Axopatch 200B amplifier (Axon Instruments Inc., Union City, 
CA). A single SMC within a confluent culture on a 12 mm glass coverslip was voltage clamped. 
A depolarization voltage pulse (10 mV, 120 ms duration) was used to generate a transient 
capacitive current. The peak current and the steady-state current were measured. Currents were 
high-cut filtered at 10 kHz and digitized at 100 kHz. The estimated conductance between the 
patched cell and its surrounding cells was calculated. Data acquisition and analysis were 
performed using the Digidata 1200A interface and pClamp6 software (Axon Instruments).  
 
Western Blot Analysis 
Protein concentrations were determined using bicinchonic acid (BCA) assay (Pierce 
Biotechnology Inc., Rockford IL). Fifty µg protein was separated by electrophoresis on 12% 
SDS-PAGE gels and transferred to a nitrocellulose membrane. The membrane was incubated 
overnight at 4°C with a rabbit anti-Cx43 antibody (1:1,000, Sigma-Aldrich C6219), or a rabbit 
anti-Cx26 antibody (1:500, Invitrogen 71-0500), or a rabbit anti-oxytocin receptor antibody 
(1:500, Abcam Ab13076, Cambridge, MA), or a mouse anti-GAPDH antibody (1:10,000, 
Chemicon MAB374, Temecula, CA). Following three washes with Tris-buffered saline with 
Tween 20 (5 min each at room temperature), infrared fluorescent-labeled secondary antibodies 
(IRDye 800 anti-rabbit, Rockland Immunochemicals 611132122, Gilbertsville, PA; Alexa680 
anti-mouse, Invitrogen A21057) were incubated at room temperature for 1 h and immunoblots 
were processed and quantified using the Odyssey infrared-imaging system (Licor). The relative 
intensities of Cx43 and Cx26 bands were determined by normalizing to GAPDH.  
 
Data Analysis and Statistics  
The data are expressed as mean ± s.e.m., with “n” denoting the number of independent 
experiments.  Comparison of two groups was carried out using a two-tailed unpaired t-test, with 
a P value below 0.05 indicating significance.  Comparison of more than two groups was carried 
out with one-way ANOVA followed by a Tukey test. Two-way ANOVA and Bonferroni test 
were used to compare two groups under different experimental conditions.  Statistical 
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significance is indicated in the graphs with a single symbol (*) for P < 0.05, double for P < 0.01, 
and triple for P < 0.001. 
 
RESULTS 
Reduced Cx43 Expression in the Myometrium of Gja1Jrt/+ Females 
Similar to what was reported in other tissues [19, 21], western blot analysis demonstrated that the 
abundance of Cx43 protein is significantly reduced in the Gja1Jrt/+ uteri (0.089 ± 0.004, n = 7 for 
Gja1Jrt/+ vs. 0.16 ± 0.01, n =6 for wildtype; P < 0.01 by two-way ANOVA) (Fig. 1A, B).  In 
particular, the phosphorylated P1 and P2 forms of Cx43 were significantly reduced (0.070 ± 
0.003), n = 7 for Gja1Jrt/+ vs. 0.13 ± 0.01, n = 6 for wildtype; P < 0.01 by two-way ANOVA).  In 
contrast, Cx26 expression level is similar between the two genotypes (0.38 ± 0.05 for Gja1Jrt/+ 
vs. 0.33 ± 0.05 for wildtype, n =8 for each group; P > 0.05 by unpaired t-test) (Fig. 1A, C), 
indicating that the Gja1Jrt mutation does not extend its effect to another member of the connexin 
family co-expressed in the uterus. Similarly, immunofluorescent labeling demonstrated that there 
are fewer Cx43 gap junction plaques present in the myometrium of the Gja1Jrt/+ females, 
although Cx43 is expressed at relatively low levels in both groups (Fig. 1D).  
 
Impaired Coupling Among Myometrial SMCs in Gja1Jrt/+ Females  
To test the effect of reduced Cx43 expression on gap junctional intercellular communication 
(GJIC), coupling levels among primary cultured myometrial SMCs were measured by single 
patch clamp as described previously [27]. Immunolabeling with SMC-specific α-actin antibody 
indicated that the purity of the SMCs was more than 90% in our preparation. Consistent with 
immunostaining of uterine tissue, the number of Cx43 gap junction plaques among the Gja1Jrt/+ 
SMCs was reduced (Fig. 2A). The estimated conductance among SMCs isolated from Gja1Jrt/+ 
females was 2.2 ± 0.4 nS (n = 5), significantly lower than that of wildtype SMCs (13.9 ± 2.0 nS, 
n = 6; P < 0.001 by unpaired t-test) (Fig. 2B), indicating that the Gja1Jrt mutant dominantly 
inhibits the function of co-expressed wildtype Cx43. 
 
Elevated Estrogen Can Not Rescue Impaired Cx43 Expression in Gja1Jrt/+ Females 
To assess whether the Gja1Jrt mutation affects the normal response of Cx43 to hormonal 
regulation, both wildtype and Gja1Jrt/+ females were treated with eCG, which elevates serum 
estradiol. As shown in Figures 3A and 3B, uterine Cx43 expression increased in both wildtype 
and Gja1Jrt/+ females in response to eCG (2.8 ± 0.3 fold increase in wildtype vs. 3.0 ± 0.1 in 
Gja1Jrt/+, n = 5 in each group). However, eCG treatment did not rescue the impaired 
phosphorylation observed in the Gja1Jrt/+ mice, indicated by a 59.7 ± 7.3 % loss of 
phosphorylated Cx43 species in the eCG-treated Gja1Jrt/+ mice compared with their wildtype 
littermates (Fig. 3C). Myometrial Cx26 expression was also significantly upregulated after eCG 
treatment in both wildtype and Gja1Jrt/+ mice (n = 4 for each group; P < 0.01, two-way 
ANOVA) but there was no significant difference between the two genotypes (no treatment, 0.37 
± 0.03 for Gja1Jrt/+ vs. 0.32 ± 0.05 for wildtype; eCG treatment, 0.51 ± 0.05 for Gja1Jrt/+ vs. 
0.53 ± 0.01 for wildtype; n =4 for each group; P > 0.05, two-way ANOVA) (Fig. 3D). This result 
confirms that the Gja1Jrt mutation specifically impaired Cx43 expression. To avoid different 
responses to eCG between groups, some mice (both wildtype and Gja1Jrt/+) were treated with 
estradiol directly. Similar changes were observed in those mice (data not shown). The 
consequence of reduced Cx43 phosphorylation on gap junction formation was evaluated by 
immunostaining. In contrast to an obvious increase of Cx43 gap junction plaques observed in the 
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wildtype myometrium after eCG treatment (not shown), there were still fewer plaques present in 
the eCG-treated Gja1Jrt/+ myometrium (Fig. 3E). 
 
Reduced Uterine Contraction in Gja1Jrt/+ Females  
To assess the effect of impaired GJIC on uterine contraction, spontaneous and oxytocin-induced 
contractile responses were quantitatively evaluated. As shown in Figure 4A, uterine strips from 
both groups displayed spontaneous contractions and dose-related excitatory responses induced 
by oxytocin. Full dose-response curves demonstrated that oxytocin evoked a significantly greater 
tension response in the wildtype uterine strips compared with the strips isolated from the 
Gja1Jrt/+ females (n = 3 for each group; P < 0.01 by two-way ANOVA) (Fig. 4B). A similar 
difference was present in uterine strips isolated from animals treated with eCG (n = 3 for each 
group; P < 0.001 by two-way ANOVA) (Fig. 4C). Western blotting failed to detect any 
difference in expression of oxytocin receptors between the two genotypes (Fig. 4D & E) (P > 
0.05, two-way ANOVA) 
 
Impaired Uterine Cx43 Expression in Late Gestational Gja1Jrt/+ Females 
To determine whether Cx43 expression is impaired in vivo during gestation, we examined the 
Cx43 expression profile in late gestational uteri (n = 5 for each group).  Consistent with previous 
studies [3, 6], we found a significant increase in Cx43 expression in wildtype uteri at 18.5 days 
pc (0.40 ± 0.02 for pregnant animals vs 0.14 ± 0.01 for nonpregnant controls; P < 0.001 by two-
way ANOVA), especially the highly phosphorylated P1 and P2 species (2.5 ± 0.2 fold increase 
vs. nonpregnant controls; P < 0.001 by two-way ANOVA) (Fig. 5A, B). In the Gja1Jrt/+ uteri, 
although Cx43 expression also increased significantly (1.8 ± 0.2 fold, P < 0.05 vs nonpregnant 
controls by two-way ANOVA), the elevation was not as great as that observed in the wildtype 
(2.9 ± 0.3 fold). Consequently, on gestational day 18.5, there was a 58.0 ± 7.4 % reduction of 
total Cx43 protein level and a 63.2 ± 2.7 % reduction of Cx43 P1/2 species in the Gja1Jrt/+ uteri 
compared with wildtype littermates (Fig. 5B, C). Consistent with the protein expression profile, 
immunolabeling demonstrated extensive Cx43 expression in the wildtype myometrium on 
gestational day 18.5, whereas little Cx43 signal was observed in the Gja1Jrt/+ myometrium (Fig. 
5E). In contrast, Cx26 expression was significantly downregulated at 18.5 days pc in both 
wildtype and Gja1Jrt/+ uteri (wildtype 0.14 ± 0.02 for pregnant animals vs 0.28 ± 0.04 for 
nonpregnant controls; Gja1Jrt/+ 0.12 ± 0.02 for pregnant animals vs 0.30 ± 0.03 for nonpregnant 
controls; P < 0.001 by two-way ANOVA, n = 9 for each group) (Fig. 5A& D). There was no 
significant difference between wildtype and Gja1Jrt/+ groups under both conditions, indicating 
that the Gja1Jrt mutation does not affect Cx26 expression in the uteri. 
 
Prolonged Gestation and Impaired Parturition of Gja1Jrt/+ Females 
After mating with wildtype males, the pregnancy rate of Gja1Jrt/+ females was significantly 
lower than their wildtype littermates. This has been characterized elsewhere [28]. The Gja1Jrt/+ 
females that become pregnant had a gestation period of 19.7 ± 0.3 days (n = 18), which is 
significantly longer (P < 0.05 by unpaired t-test) than their wildtype littermates (18.8 ± 0.2 days, 
n = 24) (Fig. 6A). Furthermore, when six of the Gja1Jrt/+ mothers were sacrificed at 2 pm on the 
day of birth, dead pups (1.4 ± 0.9 per female) were found retained in the uteri of three of them 
(Fig. 6B). In addition, significantly more placentas were found retained in the uteri of the 
Gja1Jrt/+ females (4.8 ± 0.7 for Gja1Jrt/+ females vs 0.7 ± 0.3 for wildtype; n = 6 for each group; 
P < 0.01 by unpaired t-test), indicating that parturition is impaired in the mutant females.  
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DISCUSSION 
Significant upregulation of Cx43 and enhanced connectivity within the myometrium just before 
the onset of labor indicate that Cx43-mediated intercellular communication may be critical for 
synchronized smooth muscle contraction required for normal parturition. This notion was 
confirmed by the fact that parturition was delayed in mice specifically lacking Cx43 in their 
myometrium [13]. Therefore, we hypothesized that parturition would also be compromised under 
pathological conditions when Cx43 function is impaired in mice that carry a germ line mutation 
in the gene encoding Cx43. Gja1Jrt/+ mutant mice, which have a phenotype resembling human 
ODDD, provided us with a model to study how a disease-linked Cx43 mutant can affect 
myometrial function.  
 
Several in vitro studies have demonstrated that ODDD-linked Cx43 mutations exert dominant 
negative effects on wildtype Cx43, severely limiting Cx43 mediated intercellular communication 
[1]. Consistent with these findings, we demonstrated that Cx43 expression level is also 
significantly less in the Gja1Jrt/+ myometrium, especially the phosphorylated P1 and P2 species, 
indicating that the mutant expression interferes with Cx43 reaching its normal phosphorylation 
status. In general, phosphorylation of Cx43 correlates with its assembly into functional gap 
junctions at the cell surface [1]. Thus our finding of reduced Cx43 phosphorylation in the mutant 
myometrium is consistent with the immunostaining results showing that very few Cx43-
containing gap junction plaques are present in the junctional membranes between myometrial 
smooth muscle cells. Reduced Cx43 expression and aberrant phosphorylation severely impaired 
gap junction assembly between Gja1Jrt/+ SMCs, demonstrated by an ~85% reduction of 
intercellular coupling as compared with wildtype littermates. Thus the Cx43G60S mutant is 
functionally dominant to co-expressed wildtype Cx43.  Similar effects have been observed in 
other cell types from the same Gja1Jrt/+ mice including osteoblasts [21], mammary epithelium 
[29], cardiac myocytes [30], and ovarian granulosa cells [28] as well as cardiac myocytes 
isolated from mice carrying the human ODDD-linked mutations G138R and I130T [31, 32], 
indicating that ODDD-linked Cx43 mutants interfere with normal Cx43 function in a variety of 
cell types. This negative effect seems to be specific to Cx43, since in most tissues of the ODDD 
mice, such as mammary gland and cardiac tissue, expression of other co-expressed connexins did 
not change [27, 30]. Our results concur with these findings since Cx26 expression is constant in 
the uteri of the Gja1Jrt/+ mice. Collectively, these findings indicate that Cx43 may not directly 
and promiscuously interact with other connexin family members in these tissues. However, Cx26 
was downregulated in the epidermis of adult Gja1Jrt/+ mice [33], suggesting possible cross-talk 
between Cx43 and Cx26 in the epidermis.    
 
Given the fact that myometrial Cx43 expression is under tight hormonal control, it was of 
importance to determine whether the Gja1Jrt mutation affects this regulatory mechanism. Our 
data demonstrated that, similar to what was observed in their wildtype littermates, total Cx43 
expression in Gja1Jrt/+ females increased in response to estrogen. However, total Cx43 level was 
still significantly reduced in these mice due to their lower baseline level.  More importantly, the 
nonphosphorylated form of Cx43 was the major species that responded to increased estrogen in 
the Gja1Jrt/+ uteri, resulting in a more pronounced reduction in the phosphorylated species of 
Cx43 in eCG-treated Gja1Jrt/+ females. Similar changes were observed in late gestational uteri 
when estrogen increases in vivo in association with parturition, indicating that Cx43 expression is 
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still under hormonal regulation in the Gja1Jrt/+ uteri. Despite this, the highly phosphorylated 
species of Cx43 were not rescued by the elevated estrogen level in mutant mice.  These findings 
are consistent with the hypothesis that impaired gap junctional coupling among myometrial 
SMCs of the mutant females is primarily caused by aberrant post-translational modification 
and/or trafficking of Cx43. 
 
Consistent with previous work with conditional knockout mice specifically lacking Cx43 in the 
myometrium [13], parturition defects were observed in the Gja1Jrt/+ mice. These included 
prolonged gestation as well as retained intrauterine fetuses and placentas. Correspondingly, our 
in vitro experiments showed that uterine strips isolated from Gja1Jrt/+ mice have significantly 
weaker contractions and reduced response to oxytocin as compared with strips from wildtype 
littermates. This provides further confirmation that a certain level of Cx43-mediated GJIC within 
the myometrium is critical for effective contraction.  
 
Although parturition is impaired in Gja1Jrt/+ females, mutant mice could still deliver their pups. 
Given the presence of multiple connexins in the myometrial SMCs [2], it is possible that other 
connexin isoforms may compensate for the reduced function of Cx43. However, our data 
demonstrated that ionic coupling among Gja1Jrt/+ myometrial SMCs was severely diminished, 
arguing that the compensation from other co-expressed connexins, if any, was limited. On the 
other hand, it was suggested that in addition to GJIC, coordination of SMC contractions is also 
provided by paracrine release of prostaglandin F2α and local release of calcium [34]. Another 
factor that must be considered is that myometrial cells, like the SMCs of the intestine and bladder, 
may have their contractions coordinated by the activity of interstitial cells arrayed between and 
coupled via gap junctions with SMC bundles [35]. Although Cx43 contributes to these putative 
interstitial cell junctions [35], the presence of other connexins has not been explored. These 
various alternative pathways for coordination of myometrial contraction may explain why 
parturition was impaired but not abolished in Gja1Jrt/+ females, as was also found in 
myometrium-specific Cx43 knockout mice [13].   
 
Finally, the impaired parturition observed in Gja1Jrt/+ females raises a concern that human 
ODDD females may have potential delivery problems. Given the highly variable length of 
human delivery, problems like prolonged delivery or increased Caesarean section rates may not 
have been recognized. Therefore, further clinical assessments of ODDD patients at the time of 
delivery are warranted.  
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FIGURE LEGENDS 
FIG. 1. Reduction of Cx43 expression in the myometrium of Gja1Jrt/+ females (A) 
Representative western blots showing expression of Cx43 and Cx26 in uteri from nonpregnant 
wildtype and Gja1Jrt/+ females relative to GAPDH. (B) Quantification of western blots 
demonstrated that the abundance of total Cx43 (Cx43) and the phosphorylated P1 and P2 forms 
of Cx43 (Cx43-P1/2) are significantly reduced in the Gja1Jrt/+ uteri (P < 0.01). (C) 
Quantification of western blots demonstrated that the abundance of Cx26 in the myometrium 
from Gja1Jrt/+ mice is not significantly different (P > 0.05) from that of wildtype littermates. (D) 
Representative micrographs showing uterine tissue from wildtype and Gja1Jrt/+ females double 
immunolabeled for Cx43 (green) and α-actin (red). CM, circular muscle layer; LM, longitudinal 
muscle layer; scale bar = 20 µm. 
  
FIG. 2. Impaired coupling between myometrial SMCs in Gja1Jrt/+ females (A) 
Representative micrographs showing primary cultured smooth muscle cells (SMCs) isolated 
from wildtype  and Gja1Jrt/+ females double immunolabeled for Cx43 (green) and α-actin (red); 
scale bar = 20 µm. (B) The estimated conductance among SMCs isolated from Gja1Jrt/+ females 
was significantly lower than that of wildtype SMCs (P < 0.001). 
 
FIG. 3. Elevated estrogen can not rescue impaired Cx43 expression in Gja1Jrt/+ females (A) 
Representative western blots showing expression of Cx43 and Cx26 in nonpregnant uteri from 
wildtype and Gja1Jrt/+ females treated with eCG. (B) Cx43 expression increased in both 
wildtype and Gja1Jrt/+ females in response to eCG. However, Gja1Jrt/+ females have 
significantly lower Cx43 expression level in both control (P < 0.01) and eCG treated groups (P < 
0.001).  (C) Phosphorylated P1 and P2 forms of Cx43 (Cx43-P1/2) are significantly reduced in 
the Gja1Jrt/+ uteri in both control (P < 0.1) and eCG treated groups (P < 0.001). (D) Uterine 
Cx26 expression was significantly upregulated after eCG treatment in both wildtype and 
Gja1Jrt/+ mice (P < 0.01) and there was no significant difference between the two genotypes (P > 
0.05). (E) Representative micrographs showing uterine tissue from eCG treated wildtype and 
Gja1Jrt/+ females double immunolabeled for Cx43 (green) and α-actin (red). CM, circular muscle 
layer; LM, longitudinal muscle layer; scale bar = 20 µm.  
 
FIG. 4. Reduced uterine contraction in Gja1Jrt/+ females (A) Sample traces showing activity 
of uterine strips taken from nonpregnant, wildtype and Gja1Jrt/+ females in response to oxytocin. 
The dotted line indicates baseline tension at 0 gram. (B, C) The oxytocin dose response curve is 
expressed as a percentage of a reference contraction induced by hypotonic shock in control 
animals (B) and eCG treated animals (C). In both cases, uterine strips isolated from Gja1Jrt/+ 
females showed a significantly weaker tension response compared with wildtype strips (P < 
0.001 for both graphs). (D) Representative western blots showing expression of oxytocin 
receptor (OTR) in uterine myometrium from wildtype and Gja1Jrt/+ females. (E) The abundance 
of OTR in myometrium from Gja1Jrt/+ mice is not significantly different (P > 0.05) from that of 
wildtype littermates in both the control group and the eCG-treated group. 
 
FIG. 5. Impaired Cx43 expression in Gja1Jrt/+ late gestational uteri (A) Representative 
western blots showing Cx43 and Cx26 expression in nonpregnant and gestational day 18.5 
(G18.5) uteri isolated from wildtype and Gja1Jrt/+ females. (B) The abundance of total Cx43 is 
significantly reduced in both the nonpregnant (P < 0.05) and gestational 18.5 day Gja1Jrt/+ 
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myometrium (P < 0.001). (C) The phosphorylated P1 and P2 forms of Cx43 (Cx43-P1/2) are 
significantly reduced in both the nonpregnant (P < 0.05) and gestational 18.5 day Gja1Jrt/+ 
myometrium (P < 0.001). (D) Uterine Cx26 expression was significantly downregulated in 
gestational 18.5 day uteri in both wildtype and Gja1Jrt/+ mice (P < 0.001) and there was no 
significant difference between the genotypes (P > 0.05). (E) Representative micrographs 
showing uterine tissue from gestational day 18.5 wildtype and Gja1Jrt/+ females double 
immunolabeled for Cx43 (green) and α-actin (red). Nuclei were stained with Hoechst dye (blue). 
CM, circular muscle layer; LM, longitudinal muscle layer; Scale bar = 20 µm. 
 
FIG. 6. Prolonged gestation and impaired parturition of Gja1Jrt/+ females (A) The gestation 
period of Gja1Jrt/+ females is significantly longer (P < 0.05) than their wildtype littermates. Each 
dot represents an individual mouse and the horizontal line represents the mean for each group. 
(B) In addition to producing significantly smaller litters, Gja1Jrt/+ females gave birth to some 
stillborn pups and retained significantly more placentas in their uteri than did wildtype females 
(P < 0.001).  
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